Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 18, 2024
Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma Outcomes
Tom van den Ende, Steven C Kuijper, Yousif Widaatalla, et al.
BMC Cancer
|
June 12, 2022
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally
Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2025
Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study
Denice Kamp, Anne M May, Antoine Adenis, et al.
Genome Research
|
January 13, 2025
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling
Li-Ting Chen, Myrthe Jager, Dàmi Rebergen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 9, 2021
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
Ruben S A Goedegebuure, Esther A Kleibeuker, Francesca M Buffa, et al.
Cancer Immunology Research
|
June 27, 2023
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors
Lisa A King, Elisa C Toffoli, Myrthe Veth, et al.
Frontiers in Immunology
|
April 19, 2024
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations
Tessa S Groen-van Schooten, Micaela Harrasser, Jens Seidel, et al.
Therapeutic Advances in Medical Oncology
|
July 5, 2022
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)
Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, et al.
Nature
|
February 4, 2026
Regulatory grammar in human promoters uncovered by MPRA-based deep learning
Lucía Barbadilla-Martínez, Noud Klaassen, Vinícius H Franceschini-Santos, et al.
Molecular Oncology
|
February 25, 2014
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
Muriel X G Draht, Kim M Smits, Benjamin Tournier, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
International Journal of Radiation Oncology, Biology, Physics
|
October 18, 2024
Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma Outcomes
Tom van den Ende, Steven C Kuijper, Yousif Widaatalla, et al.
BMC Cancer
|
June 12, 2022
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally
Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2025
Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study
Denice Kamp, Anne M May, Antoine Adenis, et al.
Genome Research
|
January 13, 2025
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling
Li-Ting Chen, Myrthe Jager, Dàmi Rebergen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 9, 2021
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
Ruben S A Goedegebuure, Esther A Kleibeuker, Francesca M Buffa, et al.
Cancer Immunology Research
|
June 27, 2023
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors
Lisa A King, Elisa C Toffoli, Myrthe Veth, et al.
Frontiers in Immunology
|
April 19, 2024
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations
Tessa S Groen-van Schooten, Micaela Harrasser, Jens Seidel, et al.
Therapeutic Advances in Medical Oncology
|
July 5, 2022
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)
Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, et al.
Nature
|
February 4, 2026
Regulatory grammar in human promoters uncovered by MPRA-based deep learning
Lucía Barbadilla-Martínez, Noud Klaassen, Vinícius H Franceschini-Santos, et al.
Molecular Oncology
|
February 25, 2014
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
Muriel X G Draht, Kim M Smits, Benjamin Tournier, et al.
Page
of 7